Actavis potential purchase of Warner Chilcott would be accretive, says JPMorgan

theflyonthewall.com

JP Morgan said a potential acquisition by Actavis (ACT) for Warner Chilcott (WCRX) in the mid-$20s would be "massively accretive." and believes the story has been de-risked given the Lestrin cliff.

View Comments (0)